Requirements and Audit Considerations for 21 CFR Part 312 – Investigational New Drug Applications
21 CFR Part 312 outlines the regulatory requirements governing Investigational New Drug (IND) Applications in the United States. Compliance with these requirements is essential to ensure the safety of human subjects…
